Happy New Year to the growing #radonc community. As we start the new decade, we welcome everyone to the re-establishment of our journal club...
Oligoprogression and the Potential Role of Local Ablative Therapy
Welcome to the #RadOnc Community!
Radiation oncology plays a critical role in cancer care. Our goals are to help connect people in the field, to disseminate knowledge, and to learn how to improve radiation oncology – for clinicians and patients.
We are starting with a monthly Twitter journal club chat, but with your support and suggestions we can grow the community to add more features. Article(s) chosen will be shared on the third Friday of each month, with open comment leading up to a live chat hour on the following Sunday 8PM Central Standard Time. The chat is led by our chat moderators using @Rad_Nation on Twitter. To join the conversation, go to Twitter, typing #RadOnc into the search box on Twitter, then select ‘All’.
Latest Posts
What are the key elements of leadership in radiation oncology? How do we teach it so that radiation oncologists can maintain a leading role in cancer...
Traditionally, journal clubs analyze articles to help professionals improve their knowledge so they can help patients. We share our insights with...
Usually we have a journal club every third weekend. As we approach three years of #radonc journal club, it seemed well past time to ask: what can we...
Although only semiofficial, it’s anal cancer awareness day this Tuesday. We will be discussing a review article on chemoradiation for anal...
In honor of World Cancer Day earlier this month, our February #radonc journal club will focus on global radiation therapy. Thanks to Clinical...
Everyone will remember 2016. The history books will discuss the seismic political changes and we may remember what seems like a premature and cruel...
For our November #radonc journal club we will discuss the use of radiation therapy in metastatic prostate cancer. Adding chemotherapy shows some...
For our October #radonc journal club we will discuss hypofractionated prostate radiation with daily doses > 2 Gray. What are the data, and how...